SALIVARY GLAND CANCER
Clinical trials for SALIVARY GLAND CANCER explained in plain language.
Never miss a new study
Get alerted when new SALIVARY GLAND CANCER trials appear
Sign up with your email to follow new studies for SALIVARY GLAND CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancer: experimental drug targets tumor defense
Disease control OngoingThis study is testing a new oral drug called APG-115 for people with a specific type of advanced salivary gland cancer. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. It involves 41 participants whose cancer has a normal p53 gene an…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Immunotherapy trial offers hope for advanced cancer patients out of options
Disease control OngoingThis study tested an immunotherapy drug called pembrolizumab in people with many different types of advanced solid tumors that had stopped responding to standard treatments. The main goal was to see if the drug could shrink tumors and to identify biological markers that might pre…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug duo targets Tough-to-Treat salivary gland cancers
Disease control OngoingThis study is testing whether two existing cancer drugs, lenvatinib and pembrolizumab, work together to treat advanced salivary gland cancers that have come back or spread. It will involve about 64 adults whose cancer has progressed and is no longer curable with standard treatmen…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for Tough-to-Treat head and neck cancers
Disease control OngoingThis study is testing whether combining an immunotherapy drug (pembrolizumab) with a chemotherapy drug (docetaxel) can help control advanced thyroid and salivary gland cancers that have not responded well to standard treatments. It is for adults with these specific cancers who ha…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC